SEC Form 4 · accession 0001645627-17-000065
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 17, 2017
Accepted (ET)
May 19, 2017 · 10:57 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 17, 2017 | P | 1,000 | $0.0619 | A | 20,829,949 | D | |
| Common Stock | May 17, 2017 | P | 1,000 | $0.0616 | A | 20,830,949 | D | |
| Common Stock | May 17, 2017 | P | 1,000 | $0.0619 | A | 20,831,949 | D | |
| Common Stock | May 17, 2017 | P | 1,000 | $0.059 | A | 20,832,949 | D | |
| Common Stock | May 17, 2017 | P | 1,000 | $0.059 | A | 20,833,949 | D | |
| Common Stock | May 17, 2017 | P | 1,000 | $0.06 | A | 20,834,949 | D | |
| Common Stock | May 17, 2017 | P | 1,000 | $0.06 | A | 20,835,949 | D | |
| Common Stock | May 17, 2017 | P | 1,000 | $0.06 | A | 20,836,949 | D | |
| Common Stock | May 17, 2017 | P | 1,000 | $0.0599 | A | 20,837,949 | D | |
| Common Stock | May 17, 2017 | P | 1,000 | $0.06 | A | 20,838,949 | D | |
| Common Stock | May 17, 2017 | P | 1,000 | $0.0599 | A | 20,839,949 | D | |
| Common Stock | May 17, 2017 | P | 1,000 | $0.06 | A | 20,840,949 | D | |
| Common Stock | May 17, 2017 | P | 1,000 | $0.06 | A | 20,841,949 | D | |
| Common Stock | May 17, 2017 | P | 1,000 | $0.06 | A | 20,842,949 | D | |
| Common Stock | May 17, 2017 | P | 1,000 | $0.0577 | A | 20,843,949 | D | |
| Common Stock | May 17, 2017 | P | 1,000 | $0.058 | A | 20,844,949 | D | |
| Common Stock | May 17, 2017 | P | 1,000 | $0.058 | A | 20,845,949 | D | |
| Common Stock | May 17, 2017 | P | 1,000 | $0.058 | A | 20,846,949 | D |
Table II — derivative securities
No Table II lines on this filing.